1-(Piperidine-4-carbonyl)piperidine-4-carboxylic acid, 95%, 250mg

4,4-Dimethyl-L-proline hydrochloride, 97.0%, 1g

Methyl 5-nitro-1H-imidazole-2-carboxylate, 97.0%, 1g

2-(3-Chloro-5-isopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 250mg

N-[(1,1-Dimethylethoxy)carbonyl]-D-homocysteine, 98%, 100mg

Objetivo Plan semi apocromático PLM 100x/0,80 LWD IOS. Distancia de trabajo 2,1 mm. Sin corrección de cubreobjetos

4-(2-Chloro-pyridin-4-yloxy)-phenylamine, 97%, 100mg

[3-(1-methyl-1H-benzimidazol-2-yl)propyl]amine dihydrochloride hydrate, 95.0%, 1g

1-(3-Bromo-4-methylphenylsulfonyl)pyrrolidine, 98%, 100g

5-Bromo-7H-benzo[c]carbazole, 98%, 25g

2-chloro-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]acetamide, 95+%, 500mg

(2R,2'R,3R,3'R)-4,4'-Di(anthracen-9-yl)-3,3'-di-tert-butyl-2,2',3,3'-tetrahydro-2,2'-bibenzo[d][1,3]oxaphosphole, 97%, 250mg

3-Methyl-1H-pyrrolo[3,2-b]pyridine, 95.0%, 250mg